Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade glioma

8 May 2021

Abstract excerpt

PURPOSE: Gliomas are the most frequent primary brain tumors of adults. Despite intensive research, there are still no targeted therapies available. Here, we performed an integrated analysis of glioma and programmed cell death ligand 1 (PD-L1) in 90 samples including 58 glioma and 32 control brain tissues. METHODS: To identify PD-L1 expression in glioma, we performed immunohistochemical analysis of PD-L1 tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Glioma Diagnosis and Treatment
Share to Melanoma and MAPK Pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33963441
DOI: 10.1007/s00432-021-03656-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade gliomaPMID 33963441Read ↗

Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain gliomaSemantic proximity Read ↗

Comprehensive analysis of PD-L1 expression in glioblastoma multiforme.Semantic proximity Read ↗

The Change of Soluble Programmed Cell Death-Ligand 1 in Glioma Patients Receiving Radiotherapy and Its Impact on Clinical Outcomes.Semantic proximity Read ↗

Programmed Death Ligand-1 Expression in Gliomas: A Study of Histopathological and Molecular Associations.Semantic proximity Read ↗

Expression of programmed cell death-ligand 1 and its correlation with clinical outcomes in gliomasSemantic proximity Read ↗

The Change of Soluble Programmed Cell Death-Ligand 1 (sPD-L1) in Glioma Patients Receiving Radiotherapy and Its Impact on Clinical OutcomeSemantic proximity Read ↗

PD-L1-related LncRNAs are Associated with Immune Microenvironment and Prognosis in GliomaSemantic proximity Read ↗

PD-1 related transcriptome profile and clinical outcome in diffuse gliomasSemantic proximity Read ↗

Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies.Semantic proximity Read ↗

Characterization of clinical significance of PD-1/PD-Ls expression and methylation in patients with low grade gliomaSemantic proximity Read ↗

A radiosensitivity gene signature and PD-L1 predict the clinical outcomes of patients with lower grade glioma in TCGA.Semantic proximity Read ↗

PDCD2 as a prognostic biomarker in glioma correlates with malignant phenotypeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.